Mylan Skeptical of Rumored Teva Bid; Hasn't Received Offer

April 17, 2015 8:02 PM

52 0

Generic drugmaker Mylan, citing media speculation that Teva Pharmaceutical may be eyeing it as a takeover target, says it doubts that regulators would approve such a deal and says it is committed to its current strategy as a stand-alone company.

In a news release Friday, Mylan said that it hasn't received an offer and described the idea that Teva might want to buy it as a rumor.

Also read: ECB sets Banco Popular's 2017 capital level at 7.875 percent

Read more

To category page

Loading...